image
Healthcare - Medical - Devices - NASDAQ - US
$ 80.48
-8.92 %
$ 2.7 B
Market Cap
91.45
P/E
CASH FLOW STATEMENT
-13 M OPERATING CASH FLOW
71.57%
-194 M INVESTING CASH FLOW
-355.79%
400 M FINANCING CASH FLOW
138.45%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis TransMedics Group, Inc.
image
Net Income -25 M
Depreciation & Amortization 8.18 M
Capital Expenditures -179 M
Stock-Based Compensation 19.8 M
Change in Working Capital -44.3 M
Others 40.6 M
Free Cash Flow -192 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (25.0) (36.2) (44.2) (28.7) (33.5) (23.8) (20.8) (24.1)
Depreciation & Amortization 8.2 3.5 1.8 1.6 1.2 0.8 0.6 0.4
Deferred Income Tax (1.7) 0 2.3 (0.4) 0.3 1.0 (0.3) 0.3
Stock Based Compensation 19.8 10.3 6.9 2.4 0.9 0.1 70 K 45 K
Other Operating Activities 30.0 3.4 1.4 0.5 0.5 0.2 93 K 65 K
Change in Working Capital (44.3) (26.8) 3.0 (5.6) (1.6) (4.3) (2.8) (0.9)
Cash From Operations (13.0) (45.8) (28.9) (30.3) (32.3) (26.0) (23.1) (24.1)
INVESTING CASH FLOW
Capital Expenditures (179.1) (11.9) (3.5) (0.5) (0.2) (0.4) (0.3) (1.5)
Other Items (14.9) 66.4 32.8 (41.1) (60.3) 12.7 25.1 (38.2)
Cash From Investing Activities (194.0) 54.5 29.3 (41.6) (60.5) 12.3 24.9 (39.7)
FINANCING CASH FLOW
Common Stock Repurchased 1.0 0 0.4 0 0 0 0 0
Total Debt Repaid 445.4 22.5 0 0 0 24.4 0 0
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities (52.1) 5.6 1.4 0.6 (4.6) (2.3) 3 K 63.5
Cash From Financing Activities 400.4 167.9 1.4 75.5 92.7 22.1 3 K 63.5
CHANGE IN CASH
Net Change In Cash 193.6 175.6 1.0 4.5 (0.1) 8.3 2.1 (0.2)
FREE CASH FLOW
Free Cash Flow (192.1) (57.7) (32.4) (30.7) (32.5) (26.4) (23.4) (25.6)